![Bruce Given](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bruce Given
Direttore/Membro del Consiglio presso
Vapogenix, Inc.
Profilo
Bruce D.
Given is currently Director at Vapogenix, Inc. and Pulmotect, Inc., serves on the Board of Advisor at InCube Venture Partners LLC, and is associated with Gauge Capital LLC since 2022.
Formerly, Dr. Given was President, Chief Executive Officer & Director at Encysive Pharmaceuticals, Inc. from 2002 to 2011; Chief Executive Officer at Leonardo BioSystems, Inc. from 2010 to 2014; Chairman at ICON plc from 2010 to 2013; Director at SemBioSys Genetics, Inc. in 2012; Director at Calando Pharmaceuticals, Inc. from 2010 to 2014; Director at BioHouston, Inc. from 2000 to 2012; President-International at Johnson & Johnson; COO, Head-Research & Development at Arrowhead Pharmaceuticals, Inc. from 2011 to 2020; President-International at Ortho-Clinical Diagnostics, Inc.; Group Vice President & Head-US Marketing at Janssen Pharmaceutica NV; President at Bruce Given Consulting; and Chief Medical Scientist at Arrowhead Pharmaceuticals, Inc. Education includes undergraduate studies at Colorado State University and a doctorate from Pritzker School of Medicine.
Ultime notizie su Bruce Given
Posizioni attive di Bruce Given
| Società | Posizione | Inizio |
|---|---|---|
Vapogenix, Inc.
 Vapogenix, Inc. Medical/Nursing ServicesHealth Services Operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain | Direttore/Membro del Consiglio | - |
Pulmotect, Inc.
 Pulmotect, Inc. BiotechnologyHealth Technology Develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections | Direttore/Membro del Consiglio | - |
InCube Venture Partners LLC
 InCube Venture Partners LLC Investment ManagersFinance InCube Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, healthcare and medical devices. It provides financing for early, mid and late stage capital requirements. | Consulente / Consigliere | - |
Precedenti posizioni note di Bruce Given
| Società | Posizione | Fine |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Direttore operativo | 01/05/2020 |
Calando Pharmaceuticals, Inc.
 Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | Direttore/Membro del Consiglio | 01/10/2014 |
Leonardo BioSystems, Inc.
 Leonardo BioSystems, Inc. Packaged SoftwareTechnology Services Prepackaged Software | Amministratore Delegato | 01/10/2014 |
| ICON PUBLIC LIMITED COMPANY | Presidente | 01/01/2013 |
BioHouston, Inc.
 BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in life science and biotechnology commercialization | Direttore/Membro del Consiglio | - |
Formazione di Bruce Given
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
70
Relazioni di 1° grado
16
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 16 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
ICON plc
 ICON plc Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services | Commercial Services |
SemBioSys Genetics, Inc.
 SemBioSys Genetics, Inc. BiotechnologyHealth Technology Develops protein-based pharmaceuticals and non-pharmaceutical products | Health Technology |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | Health Technology |
Vapogenix, Inc.
Vapogenix, Inc. Medical/Nursing ServicesHealth Services Operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain | Health Services |
Ortho-Clinical Diagnostics, Inc.
 Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Manufactures and designs diagnostic, transfusion, and clinical equipment and systems | Health Technology |
Colorado State University
 Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioHouston, Inc.
BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in life science and biotechnology commercialization | Commercial Services |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Health Technology |
InCube Venture Partners LLC
InCube Venture Partners LLC Investment ManagersFinance InCube Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, healthcare and medical devices. It provides financing for early, mid and late stage capital requirements. | Finance |
Leonardo BioSystems, Inc.
Leonardo BioSystems, Inc. Packaged SoftwareTechnology Services Prepackaged Software | Technology Services |
Pritzker School of Medicine
 Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pulmotect, Inc.
Pulmotect, Inc. BiotechnologyHealth Technology Develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections | Health Technology |
Bruce Given Consulting |
